Dermatophytosis medical therapy

Dermatophytosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatophytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiographic Findings
X-Ray Findings
CT scan Findings
MRI Findings
Ultrasound Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatophytosis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatophytosis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onDermatophytosis medical therapy
CDC on Dermatophytosis medical therapy
Dermatophytosis medical therapy in the news
Blogs on Dermatophytosis medical therapy
Directions to Hospitals Treating Dermatophytosis here
Risk calculators and risk factors for Dermatophytosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Topical antifungals

Azoles	Preparation	Infection site	Application frequency	Duration of treatment
Clotrimazole	Cream, lotion	T. corporis/cruris/pedis	BD	4-6 weeks
Econazole	Cream	T. corporis/cruris/pedis	OD-BD	4-6 weeks
Miconazole	Cream, lotion	T. corporis/cruris/pedis	BD	4-6 weeks
Oxiconazole	Cream, lotion	T. corporis/cruris/pedis	OD-BD	4 weeks
Sertaconazole	Cream	T. corporis/cruris/pedis	BD	4 weeks
Luliconazole	Cream, lotion	T. corporis/cruris/pedis	OD	2 weeks
Eberconazole	Cream	T. corporis/cruris/pedis	OD	2-4 weeks
Efinaconazole	Solution	T. pedis	OD	Up to 52 weeks
Terbinafine	Cream, powder	T. corporis	BD	2 weeks
		T. cruris	BD	2 weeks
		T. pedis	BD	4 weeks
		T. manum	BD	4 weeks
Naftifine 1%	Cream	T. corporis/cruris/pedis	OD-BD	2 weeks beyond symptom resolution
Butenafine 1%	Cream	T. corporis/cruris/pedis	OD-BD	2-4 weeks
Amolorfine 0.25%	Cream	T. corporis	BD	4 weeks
Amphotericin B 1mg	Lipid based gel	T. corporis	BD	2 weeks

Indication of systemic antifungal therapy in dermatophytosis

The following are the situations where systemic antifungal therapy may be preferred

• Tinea capitis.
• Onychomycosis.
• Tinea affecting more than one body part simultaneously, for example, tinea cruris and corporis, or tinea cruris and tinea pedis
• Widespread Tinea corporis.
• Widespread Tinea pedis of the sole, heel, or dorsum of the foot or when there is blistering.